{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:05:49Z","timestamp":1789679149052,"version":"4.0.1"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012272","name":"Shenzhen Technology Development Program","doi-asserted-by":"publisher","award":["LCYSSQ20220823091401002"],"award-info":[{"award-number":["LCYSSQ20220823091401002"]}],"id":[{"id":"10.13039\/501100012272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.trecan.2026.08.008","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:42:11Z","timestamp":1789443731000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fusion-product control in hematologic cancers"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3462-3711","authenticated-orcid":false,"given":"Min","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6872-2665","authenticated-orcid":false,"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2026.08.008_bb0005","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood.2025031480","article-title":"2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party","volume":"147","author":"Cloos","year":"2026","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2026.08.008_bb0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41568-019-0132-x","article-title":"Targeting chromatin complexes in fusion protein-driven malignancies","volume":"19","author":"Brien","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2026.08.008_bb0015","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1038\/s41375-023-01950-9","article-title":"Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo","volume":"37","author":"Neldeborg","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.trecan.2026.08.008_bb0020","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41375-023-01854-8","article-title":"Nanoparticle-mediated targeting of the fusion gene RUNX1\/ETO in t(8;21)-positive acute myeloid leukaemia","volume":"37","author":"Issa","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.trecan.2026.08.008_bb0025","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1182\/blood.2025028988","article-title":"Fusion gene depletion eliminates stemness and induces bidirectional differentiation of acute myeloid leukemia","volume":"146","author":"Derevyanko","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2026.08.008_bb0030","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1038\/s41375-026-03051-9","article-title":"EIF4A3-dependent nonsense-mediated decay buffers AML1-ETO9a dosage and modulates outcome in t(8;21) acute myeloid leukemia","volume":"40","author":"Zhang","year":"2026","journal-title":"Leukemia"},{"key":"10.1016\/j.trecan.2026.08.008_bb0035","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adt9100","article-title":"USP5 inhibition enables potential therapy for t(8;21) AML through ubiquitin-mediated AML1-ETO degradation in patient-derived xenografts","volume":"17","author":"Ma","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.trecan.2026.08.008_bb0040","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1038\/s41375-025-02698-0","article-title":"Deubiquitinase USP6 stabilizes oncogenic RUNX1 fusion proteins to promote the leukemic potential and malignant progression","volume":"39","author":"Zhang","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.trecan.2026.08.008_bb0045","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.molcel.2022.02.013","article-title":"MLL::AF9 degradation induces rapid changes in transcriptional elongation and subsequent loss of an active chromatin landscape","volume":"82","author":"Olsen","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.trecan.2026.08.008_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116602","article-title":"Harnessing the E3 ligase SPOP for targeted degradation of the NUP98::KDM5A fusion oncoprotein","volume":"44","author":"Kirkiz","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.trecan.2026.08.008_bb0055","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1038\/s41467-023-37438-4","article-title":"Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2026.08.008_bb0060","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.molcel.2020.12.005","article-title":"Definition of a small core transcriptional circuit regulated by AML1-ETO","volume":"81","author":"Stengel","year":"2021","journal-title":"Mol. Cell"}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803326002049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803326002049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:59:31Z","timestamp":1789678771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405803326002049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":12,"alternative-id":["S2405803326002049"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2026.08.008","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fusion-product control in hematologic cancers","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2026.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}